Ultrafast dynamics of the indoline dye D149 on electrodeposited ZnO and sintered ZrO2 and TiO2 thin films

The ultrafast photoinjection and subsequent relaxation steps of the indoline dye D149 were investigated in detail for a mesoporous electrodeposited ZnO thin film and compared with experiments on sintered TiO2 and ZrO2 thin films, all in contact with air, using pump-supercontinuum probe (PSCP) transient absorption spectroscopy in the range 370-770 nm. D149 efficiently injects electrons into the ZnO surface with time constants from ≤70 fs (time-resolution-limited) up to 250 fs, without the presence of slower components. Subsequent spectral dynamics with a time constant of 20 ps and no accompanying change in the oscillator strength are assigned to a transient Stark shift of the electronic absorption spectrum of D149 molecules in the electronic ground state due to the local electric field exerted by the D149 •+ radical cations and conduction band electrons in ZnO. This interpretation is consistent with the shape of the relaxed PSCP spectrum at long times, which resembles the first derivative of the inverted steady-state absorption spectrum of D149. In addition, steady-state difference absorption spectra of D149•+ in solution from spectroelectrochemistry display a bleach band with distinctly different position, because no first-order Stark effect is present in that case. Interference features in the PSCP spectra probably arise from a change of the refractive index of ZnO caused by the injected electrons. The 20 ps component in the PSCP spectra is likely a manifestation of the transition from an initially formed bound D149 •+-electron complex to isolated D149•+ and mobile electrons in the ZnO conduction band (which changes the external electric field experienced by D149) and possibly also reorientational motion of D149 molecules in response to the electric field. We identify additional spectral dynamics on a similar timescale, arising from vibrational relaxation of D149•+ by interactions with ZnO. TiO2 exhibits similar dynamics to ZnO. In the case of ZrO2, electron injection accesses trap states, which exhibit a substantial probability for charge recombination. No Stark shift is observed in this case. In addition, the spectroelectrochemical experiments for D149•+ in dichloromethane and acetonitrile, which cover the spectral range up to 2000 nm, provide for the first time access to its complete D0 → D1 absorption band, with the peak located at 1250 and 1055 nm, respectively. Good agreement is obtained with results from DFT/TDDFT calculations of the D149 •+ spectrum employing the MPW1K functional. © 2012 the Owner Societies

Ultrafast photoinduced relaxation dynamics of the indoline dye D149 in organic solvents

The relaxation dynamics of the indoline dye D149, a well-known sensitizer for photoelectrochemical solar cells, have been extensively characterized in various organic solvents by combining results from ultrafast pump–supercontinuum probe (PSCP) spectroscopy, transient UV-pump VIS-probe spectroscopy, time-correlated single-photon counting (TCSPC) measurements as well as steady-state absorption and fluorescence. In the steady-state spectra, the position of the absorption maximum shows only a weak solvent dependence, whereas the fluorescence Stokes shift Δ[small nu, Greek, tilde]F correlates with solvent polarity. Photoexcitation at around 480 nm provides access to the S1 state of D149 which exhibits solvation dynamics on characteristic timescales, as monitored by a red-shift of the stimulated emission and spectral development of the excited-state absorption in the transient PSCP spectra. In all cases, the spectral dynamics can be modeled by a global kinetic analysis using a time-dependent S1spectrum. The lifetime τ1 of the S1 state roughly correlates with polarity [acetonitrile (280 ps) < acetone (540 ps) < THF (720 ps) < chloroform (800 ps)], yet in alcohols it is much shorter [methanol (99 ps) < ethanol (178 ps) < acetonitrile (280 ps)], suggesting an appreciable influence of hydrogen bonding on the dynamics. A minor component with a characteristic time constant in the range 19–30 ps, readily observed in the PSCP spectra of D149 in acetonitrile and THF, is likely due to removal of vibrational excess energy from the S1 state by collisions with solvent molecules. Additional weak fluorescence in the range 390–500 nm is observed upon excitation in the S0 → S2 band, which contains short-lived S2 → S0 emission of D149. Transient absorption signals after excitation at 377.5 nm yield an additional time constant in the subpicosecond range, representing the lifetime of the S2 state. S2 excitation also produces photoproducts

Wald und Klimawandel

Das Forschungscamp Wald und Klimaandel entstand in Kooperation von Schule, Revierförsterei und zweier Hochschulen. Der Leitfaden stellt das Konzept des "Forschungscamps Wald und Klimawandel" vor und soll als Hilfestellung bei der Planung, Durchführung und Evaluierung ähnlicher Bildungsangebote dienen. Außerdem bietet er Anregungen für die Gestaltung von Lernortkooperationen zwischen außerschulischen, schulischen und wissenschaftlichen Institutionen.Not Reviewe

Reporting bias in medical research - a narrative review

Reporting bias represents a major problem in the assessment of health care interventions. Several prominent cases have been described in the literature, for example, in the reporting of trials of antidepressants, Class I anti-arrhythmic drugs, and selective COX-2 inhibitors. The aim of this narrative review is to gain an overview of reporting bias in the medical literature, focussing on publication bias and selective outcome reporting. We explore whether these types of bias have been shown in areas beyond the well-known cases noted above, in order to gain an impression of how widespread the problem is. For this purpose, we screened relevant articles on reporting bias that had previously been obtained by the German Institute for Quality and Efficiency in Health Care in the context of its health technology assessment reports and other research work, together with the reference lists of these articles

Does administration of non-steroidal anti-inflammatory drug determine morphological changes in adrenal cortex: ultrastructural studies

Rofecoxib (Vioxx© made by Merck Sharp & Dohme, the USA) is a non-steroidal anti-inflammatory drug which belongs to the group of selective inhibitors of cyclooxygenasis-2, i.e., coxibs. Rofecoxib was first registered in the USA, in May 1999. Since then the drug was received by millions of patients. Drugs of this group were expected to exhibit increased therapeutic action. Additionally, there were expectations concerning possibilities of their application, at least as auxiliary drugs, in neoplastic therpy due to intensifying of apoptosis. In connection with the withdrawal of Vioxx© (rofecoxib) from pharmaceutical market, attempts were made to conduct electron-microscopic evaluation of cortical part of the adrenal gland in preparations obtained from animals under influence of the drug. Every morning animals from the experimental group (15 rats) received rofecoxib (suspension in physiological saline)—non-steroidal anti-inflammatory drug (Vioxx©, Merck Sharp and Dohme, the USA), through an intragastric tube in the dose of 1.25 mg during 8 weeks. In the evaluated material, there was found a greater number of secretory vacuoles and large, containing cholesterol and other lipids as well as generated glucocorticoids, lipid drops in cytoplasm containing prominent endoplasmic reticulum. There were also found cells with cytoplasm of smaller density—especially in apical and basal parts of cells. Mitochondria occasionally demonstrated features of delicate swelling. The observed changes, which occurred on cellular level with application of large doses of the drug, result from mobilization of adaptation mechanisms of the organism

Status Update and Interim Results from the Asymptomatic Carotid Surgery Trial-2 (ACST-2)

Objectives: ACST-2 is currently the largest trial ever conducted to compare carotid artery stenting (CAS) with carotid endarterectomy (CEA) in patients with severe asymptomatic carotid stenosis requiring revascularization. Methods: Patients are entered into ACST-2 when revascularization is felt to be clearly indicated, when CEA and CAS are both possible, but where there is substantial uncertainty as to which is most appropriate. Trial surgeons and interventionalists are expected to use their usual techniques and CE-approved devices. We report baseline characteristics and blinded combined interim results for 30-day mortality and major morbidity for 986 patients in the ongoing trial up to September 2012. Results: A total of 986 patients (687 men, 299 women), mean age 68.7 years (SD ± 8.1) were randomized equally to CEA or CAS. Most (96%) had ipsilateral stenosis of 70-99% (median 80%) with contralateral stenoses of 50-99% in 30% and contralateral occlusion in 8%. Patients were on appropriate medical treatment. For 691 patients undergoing intervention with at least 1-month follow-up and Rankin scoring at 6 months for any stroke, the overall serious cardiovascular event rate of periprocedural (within 30 days) disabling stroke, fatal myocardial infarction, and death at 30 days was 1.0%. Conclusions: Early ACST-2 results suggest contemporary carotid intervention for asymptomatic stenosis has a low risk of serious morbidity and mortality, on par with other recent trials. The trial continues to recruit, to monitor periprocedural events and all types of stroke, aiming to randomize up to 5,000 patients to determine any differential outcomes between interventions. Clinical trial: ISRCTN21144362. © 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved

Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy

Background: Among asymptomatic patients with severe carotid artery stenosis but no recent stroke or transient cerebral ischaemia, either carotid artery stenting (CAS) or carotid endarterectomy (CEA) can restore patency and reduce long-term stroke risks. However, from recent national registry data, each option causes about 1% procedural risk of disabling stroke or death. Comparison of their long-term protective effects requires large-scale randomised evidence. Methods: ACST-2 is an international multicentre randomised trial of CAS versus CEA among asymptomatic patients with severe stenosis thought to require intervention, interpreted with all other relevant trials. Patients were eligible if they had severe unilateral or bilateral carotid artery stenosis and both doctor and patient agreed that a carotid procedure should be undertaken, but they were substantially uncertain which one to choose. Patients were randomly allocated to CAS or CEA and followed up at 1 month and then annually, for a mean 5 years. Procedural events were those within 30 days of the intervention. Intention-to-treat analyses are provided. Analyses including procedural hazards use tabular methods. Analyses and meta-analyses of non-procedural strokes use Kaplan-Meier and log-rank methods. The trial is registered with the ISRCTN registry, ISRCTN21144362. Findings: Between Jan 15, 2008, and Dec 31, 2020, 3625 patients in 130 centres were randomly allocated, 1811 to CAS and 1814 to CEA, with good compliance, good medical therapy and a mean 5 years of follow-up. Overall, 1% had disabling stroke or death procedurally (15 allocated to CAS and 18 to CEA) and 2% had non-disabling procedural stroke (48 allocated to CAS and 29 to CEA). Kaplan-Meier estimates of 5-year non-procedural stroke were 2·5% in each group for fatal or disabling stroke, and 5·3% with CAS versus 4·5% with CEA for any stroke (rate ratio [RR] 1·16, 95% CI 0·86–1·57; p=0·33). Combining RRs for any non-procedural stroke in all CAS versus CEA trials, the RR was similar in symptomatic and asymptomatic patients (overall RR 1·11, 95% CI 0·91–1·32; p=0·21). Interpretation: Serious complications are similarly uncommon after competent CAS and CEA, and the long-term effects of these two carotid artery procedures on fatal or disabling stroke are comparable. Funding: UK Medical Research Council and Health Technology Assessment Programme

Excited-State Dynamics of Bis(tetraethylammonium) Di-µ-bromo-dibromodicuprate(I) Thin Films

Organic–inorganic halocuprates based on monovalent copper are promising luminescent compounds for optoelectronic applications; however, their relaxation processes in the excited electronic state are severely underexplored. In this contribution, we prepare thin films of bis(tetraethylammonium) di-µ-bromo-dibromodicuprate(I) [N(C2H5)4]2[Cu2Br4], abbreviated (TEA)2Cu2Br4, which features a “molecular salt” structure containing discrete [Cu2Br4]2− anions. This compound, which has an absorption peak at 283 nm, displays a blue, strongly Stokes-shifted emission with a peak at 467 nm. Transient photoluminescence (PL) experiments using broadband emission detection and time-correlated single-photon counting (TCSPC) both find an excited-state lifetime of 57 μs at 296 K. UV–Vis transient absorption experiments at 296 K covering time scales from femto- to microseconds provide evidence for the formation of the T1 state through intersystem crossing from S1 with a time constant of 184 ps. The triplet state subsequently decays to S0 predominantly by phosphorescence. In addition, the time constants for carrier–optical phonon scattering (1.8 ps) and acoustic phonon relaxation (8.3 ns and 465 ns) of (TEA)2Cu2Br4 are provided